Cardiovascular disease (CVD) risk factors and health behaviors after cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS) in the Platinum study.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Mohammad Issam Abu Zaid, Chunkit Fung, AnnaLynn Williams, Howard D. Sesso, Sarah L. Kerns, Shirin Ardeshir-Rouhani-Fard, Darren R. Feldman, Robert James Hamilton, David J. Vaughn, Clair Beard, Patrick Monahan, Sophie D. Fossa, Lawrence H. Einhorn, Lois B. Travis, for The Platinum Study Group
Institutions: Indiana University School of Medicine, University of Rochester Medicine, University of Rochester, Harvard University, Indiana University Bloomington, Indiana University, Memorial Sloan Kettering Cancer Center, University Health Network, Princess Margaret Cancer Centre, Abramson Cancer Center, University of Pennsylvania, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Oslo University Hospital, University of Oslo, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891189019